• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Momenta Pharmaceuticals Inc

+ Add to Watchlist


11.0200 USD 0.0200 0.18%

As of 20:10:00 ET on 10/24/2014.

Snapshot for Momenta Pharmaceuticals Inc (MNTA)

Open: 11.0300 Day's Range: 10.9200 - 11.1300 Volume: 325,594
Previous Close: 11.0000 52wk Range: 9.3800 - 19.9000 1-Yr Rtn: -33.97%

Stock Chart for MNTA

No chart data available.
  • MNTA:US 11.0200
  • 1D
  • 1M
  • 1Y
Interactive MNTA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MNTA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.1300
Est. EPS (USD) (12/2014) -1.5960
Est. PEG Ratio -
Market Cap (M USD) 582.00
Shares Outstanding (M) 52.81
30 Day Average Volume 533,617
Price/Book (mrq) 2.5793
Price/Sale (ttm) 12.4881
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/05/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MNTA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for MNTA

Momenta Pharmaceuticals, Inc. is a biotechnology company. The Company specializes in sequencing and engineering of complex sugars for the development of improved versions of existing drugs, the development of novel drugs, and the discovery of new biological processes. Momenta also develops technology-enabled generic products.

Craig A WheelerPresident/CEOMichael FrankenPres:Biosimilars Business/Senior VP
Richard P Shea "Rick"Senior VP/CFOBruce A LeicherSenior VP/Secy/General Cnsl
More Company Profile & Key Executives for MNTA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil